SpO2 Monitoring: How It Works, Where It Helps, and What the Accuracy Limits Really Are

What SpO2 means

SpO2 stands for peripheral capillary oxygen saturation. It is an estimate of the percentage of hemoglobin binding sites occupied by oxygen in arterial blood.

It is not the same as arterial oxygen saturation measured directly from an arterial blood gas. It is a noninvasive estimate.

That distinction matters because pulse oximetry is extremely useful, but it is still an indirect optical measurement.

How pulse oximetry works

Pulse oximetry is built on photoplethysmography, or PPG. If you want the broader sensor background, Sensor Bio already covers that in its PPG overview and modality comparison guide.

At a high level, a pulse oximeter:

1. shines red and infrared light into tissue,
2. measures how much light is absorbed,
3. separates pulsatile arterial changes from background tissue signal,
4. estimates oxygen saturation from the relative absorption pattern.

Why red and infrared light matter

Oxyhemoglobin and deoxyhemoglobin absorb light differently at different wavelengths. By comparing red and infrared absorption, the device estimates arterial oxygen saturation.

That is the core physiologic trick. Everything else, sensor placement, optics, calibration, artifact rejection, signal smoothing, is engineering.

Pulse oximetry vs. PPG-derived SpO2 from wearables

This is where buyers need to slow down.

A standard fingertip pulse oximeter is usually a transmission-mode device, meaning light passes through tissue. Many wrist-worn wearables rely on reflectance-mode PPG, where light is reflected back to the sensor.

Both are PPG. They are not the same measurement environment.

Reflectance wearables are attractive because they support longer-term monitoring and lower patient friction. They also face tougher signal conditions:

• more motion,
• more variable skin contact,
• more ambient light exposure,
• lower perfusion at the wrist versus the finger,
• more dependence on algorithmic cleanup.

That does not make wearables useless. It means validation matters.

A useful mental model is this: pulse oximetry is a specialized application of PPG, not a separate optical universe. The same sensing family can power heart rate, pulse waveform analysis, and oxygen-related estimation, but SpO2 usually places tighter demands on calibration and artifact control because the device is comparing wavelength-specific absorption rather than simply detecting pulse timing.

Where SpO2 monitoring is clinically useful

1. Pulmonary disease monitoring

For COPD and other chronic respiratory conditions, oxygen saturation can help track baseline status, symptom worsening, and potential exacerbation risk. But as Mehdipour et al. showed in a systematic review of digital monitoring devices in COPD, validity is not the same thing as strong predictive power. Devices were valid against reference monitors, yet less precise at predicting exacerbation events [2].

That is an important nuance. SpO2 is useful, but it is not a crystal ball.

2. Acute respiratory surveillance

Pulse oximetry is commonly used in acute illness because hypoxemia may not be obvious on visual inspection alone.

3. Sleep-related breathing assessment

Overnight desaturation patterns matter in sleep medicine, especially when interpreted with airflow, respiratory effort, and event scoring. Oximetry is a core part of many sleep workflows, but by itself it does not replace a full sleep study.

4. Remote recovery and post-acute monitoring

In post-discharge settings, longitudinal SpO2 trends can help support follow-up, especially when paired with symptom reports, heart rate, respiratory rate, and escalation protocols.

The biggest SpO2 accuracy problem: context

The worst way to interpret SpO2 is as an infallible number detached from conditions.

Motion artifact

When patients move, the optical signal gets messy fast. This is one reason finger devices used at rest often outperform wrist wearables during daily life.

Low perfusion

Cold extremities, shock states, vasoconstriction, and poor local perfusion can all degrade signal quality.

Sensor placement and fit

Loose wearables, misaligned sensors, nail polish in fingertip devices, and poor skin contact all matter.

Algorithm design and filtering

A polished interface can hide weak signal quality. Teams should ask what quality thresholds are enforced before displaying SpO2 values.

Population bias and skin tone effects

One of the most important pulse oximetry papers of the last decade is the 2020 New England Journal of Medicine report by Sjoding et al., which showed racial bias in pulse oximetry measurement and reignited concern about occult hypoxemia being missed in darker-skinned patients [3]. If a vendor talks about SpO2 accuracy without addressing bias and population diversity, that is a red flag.

What the literature says about wearable accuracy

Knight et al. reviewed wearable PPG sensors for telehealth monitoring and found intense interest in remote sensing, but also major inconsistency in accuracy reporting and not enough large, real-world validation studies [4]. That finding applies directly to SpO2 strategy.

The remote-monitoring market is full of devices that can generate oxygen numbers. The real question is whether those numbers are reliable enough, under real conditions, for the decisions you want to make.

A simple buyer rule helps here: the higher the clinical consequence of acting on a reading, the stronger the validation standard should be. A device that informs wellness-style trend review is one thing. A device used to trigger urgent outreach needs a much tighter evidence threshold.

For pulmonary use cases, Mehdipour et al. found evidence of validity for SpO2 devices in COPD, while also emphasizing that the literature base was small and that prediction of exacerbations remained limited [2].

Levy et al. add another layer by showing that continuous oxygen time-series analysis is richer than a single spot value. Their work on digital oximetry biomarkers used 3,806 polysomnography recordings totaling 26,686 hours of data to explore how continuous oxygen features relate to obstructive sleep apnea severity [1]. That is a useful reminder that oxygen monitoring is not just about one saturation number. The pattern over time matters.

How clinicians should interpret SpO2 in remote care

Use trends, not isolated snapshots

A single reading can be useful. A trend is usually better.

Pair SpO2 with symptoms

Shortness of breath, cough, sleep disruption, chest symptoms, activity intolerance, and therapy adherence all change how an SpO2 value should be interpreted.

Pay attention to signal quality

If the device does not surface confidence or signal-quality markers, the team should ask why.

Know when to escalate

SpO2 monitoring only helps if there is a defined response to sustained decline, abnormal overnight patterns, or symptom-linked desaturation.

Avoid overclaiming from consumer-style wearables

A wrist wearable can be very helpful for longitudinal physiology. It is not automatically a substitute for a clinical pulse oximeter in every decision context.

SpO2 in telehealth and remote monitoring programs

This is where program design matters more than gadget specs.

A good oxygen monitoring workflow answers:

• Who should be monitored?
• What baseline is considered acceptable for this patient?
• What thresholds trigger outreach?
• How is symptom context captured?
• Who reviews abnormal readings, and how quickly?
• Which readings are considered too low-confidence to act on?

Without those answers, continuous oxygen data quickly becomes background noise.

Spot checks versus continuous SpO2 trends

This distinction is more important than many dashboards admit.

A spot check is useful when the question is immediate: what is the patient’s oxygen saturation right now? A continuous or overnight trend is useful when the question is longitudinal: are desaturations recurring, worsening, or responding to treatment over time?

Teams should not treat those as interchangeable products. A wearable that is helpful for overnight trend visibility may still be the wrong tool for urgent point-in-time triage. Likewise, a fingertip pulse oximeter that is excellent for spot checks does not automatically create the kind of time-series insight that makes remote monitoring valuable.

A note on thresholds and alarm design

SpO2 thresholds should never be one-size-fits-all. Some patients have a normal baseline lower than others, especially in chronic pulmonary disease. That means remote programs need patient-specific escalation logic rather than a single universal cutoff pasted across the entire panel.

A strong workflow usually defines:

• the patient’s expected baseline range,
• the amount of drop that matters,
• whether the decline is sustained or transient,
• which symptoms convert a borderline value into an urgent issue,
• who gets notified and within what time frame.

That is less flashy than a dashboard heat map, but it is what makes oxygen monitoring clinically useful.

What digital health teams should ask before buying a device

Before adopting any SpO2 sensor, ask:

• Was validation done against a recognized reference method?
• In what population?
• At rest only, or during motion and daily life?
• How does the device perform in low perfusion states?
• How does performance vary across skin tones?
• Does the product distinguish spot checks from continuous trend analysis?
• What happens when signal quality is poor?

These are not minor procurement questions. They are the whole ballgame.

Where Sensor Bio fits

Sensor Bio’s opportunity is not to pretend that wrist-based SpO2 behaves exactly like a hospital-grade fingertip pulse oximeter in every setting. The stronger story is that continuous PPG sensing can support oxygen-trend visibility inside broader RTM workflows, especially when paired with heart rate, symptom response, sleep-related signals, and adherence data.

That is credible. It is also much more useful to serious buyers.

FAQ

What is SpO2 monitoring?

SpO2 monitoring is the noninvasive estimation of arterial oxygen saturation using optical sensing, usually through pulse oximetry.

Is SpO2 the same as oxygen measured from blood gas testing?

No. SpO2 is an estimate from optical sensing. Arterial blood gas measurement is direct and more definitive.

Can wearables measure SpO2 accurately?

Sometimes, under the right conditions. Accuracy depends on sensor design, placement, motion, perfusion, algorithm quality, and patient factors [2,4].

Why can pulse oximeters be wrong?

Common reasons include motion, poor perfusion, bad fit, ambient light, skin-tone-related bias, and algorithm limitations [3].

Is SpO2 enough to diagnose sleep apnea or respiratory disease?

No. Oximetry is useful, but diagnosis typically requires broader clinical context and, in many cases, formal testing.

References

1. Levy J, et al. Digital oximetry biomarkers for assessing respiratory function: standards of measurement, physiological interpretation, and clinical use. NPJ Digit Med. 2021;4(1):1. PMID: 33398041. https://pubmed.ncbi.nlm.nih.gov/33398041/
2. Mehdipour A, et al. The Performance of Digital Monitoring Devices for Oxygen Saturation and Respiratory Rate in COPD: A Systematic Review. COPD. 2021;18(4):469-475. PMID: 34223780. https://pubmed.ncbi.nlm.nih.gov/34223780/
3. Sjoding MW, et al. Racial Bias in Pulse Oximetry Measurement. N Engl J Med. 2020;383(25):2477-2478. PMID: 33326721. https://pubmed.ncbi.nlm.nih.gov/33326721/
4. Knight S, et al. The Accuracy of Wearable Photoplethysmography Sensors for Telehealth Monitoring: A Scoping Review. Telemed J E Health. 2023;29(6):813-828. PMID: 36288566. https://pubmed.ncbi.nlm.nih.gov/36288566/

References

References

1. Jubran A. Pulse oximetry. Critical Care. 2015;19:272.
2. Severinghaus JW, Astrup PB. History of blood gas analysis. Journal of Clinical Monitoring. 1986;2:270-288.
3. Luks AM, Swenson ER. Pulse oximetry for monitoring patients with COVID-19 at home. Annals of the American Thoracic Society. 2020;17(9):1040-1046.
4. Sjoding MW, Dickson RP, Iwashyna TJ, Gay SE, Valley TS. Racial bias in pulse oximetry measurement. New England Journal of Medicine. 2020;383:2477-2478.
5. U.S. Food and Drug Administration. Pulse oximeter accuracy and limitations: FDA safety communication.
6. Allen J. Photoplethysmography and its application in clinical physiological measurement. Physiological Measurement. 2007;28(3):R1-R39.